Kaspersky, the popular computer security firm based in Russia, has withdrawn its antitrust complaint against software giant Microsoft though the dispute is not totally gone. The security vendor lambasted Microsoft for allegedly taking advantage of its market influence to edge out antivirus providers.
The dispute arose from the new changes Microsoft introduced in the Creators Update that made Windows Defender the preferred security tool for Windows 10. The Creators Update removes some third-party security products from PCs that upgrade to the update. For Kaspersky, that means exposing users to security risks. The move also aims to force out security vendors, according to Eugene Kaspersky, founder and chief executive:
“Several years ago Microsoft decided to overhaul the Windows platform. Ostensibly this was in the name of better ease of usage, security, performance and so on. Behind the scenes what Microsoft was up to was elegantly seizing niche markets: squeezing independent developers out of them, taking their place, and offering users their own products, which in many cases were in no way better.” Said in the Kaspersky’s blog.
Full Content: Hot Hardware
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI